Glossary.

Terms used in batch records, documentation practice and process data, in plain words, with a source for each.

"N/A" and blank fields · 21 CFR Part 11 · ALCOA+ · Annual product review / product quality review (APR, PQR) · Audit trail · Batch certification · Batch manufacturing record (BMR) · Batch production record (BPR) · Computer software assurance (CSA) · Continued process verification (CPV) · Correction (on a GMP record) · Corrective and preventive action (CAPA) · Critical process parameter (CPP) · Critical quality attribute (CQA) · Deviation · Draft EU GMP Annex 22 (Artificial Intelligence) · Electronic batch record (eBR) · EU GMP Annex 11 · EU GMP Annex 16 · Executed batch record · GAMP 5 · Good documentation practice (GDP) · In-process control (IPC) · Late entry · Line clearance · Master batch record (MBR) · Master production and control record · Normal operating range (NOR) · Out of trend (OOT) · Proven acceptable range (PAR) · Qualified Person (QP) · Reconciliation · Review by exception (RBE) · Second-person verification · Transcription (of GMP data) · True copy · Yield

"N/A" and blank fields

Every place for an entry on a batch record should end up holding something: a value, a signature, or a mark that it does not apply. PIC/S PI 041-1 (section 8.6) says unused, blank fields should be voided, for example crossed out, dated and signed. Sites usually write “N/A” with initials and date, or strike through unused rows or whole sections. A field left blank could mean the step was skipped, forgotten or not needed, which a reviewer cannot tell apart, and it could be filled in later.

Source: PIC/S PI 041-1 Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments, section 8.6 · Guide: read more

21 CFR Part 11

The US FDA regulation on electronic records and electronic signatures. It sets the criteria under which FDA treats electronic records and signatures as equivalent to paper records and handwritten signatures, and it applies to records kept in electronic form under any FDA records requirement (21 CFR 11.1). Its controls include system validation, secure computer-generated audit trails, limited access and signature manifestations. A spreadsheet or database of values taken from batch records can fall within its scope when it is used to meet a GMP requirement; the site’s own assessment decides.

Source: 21 CFR Part 11 Electronic records; electronic signatures

ALCOA+

An acronym for the qualities GMP data should have: attributable, legible, contemporaneous, original and accurate, with complete, consistent, enduring and available added by the plus. The WHO guideline on data integrity (TRS 1033, Annex 4) defines it this way, and PIC/S PI 041-1 uses the same list. On a batch record it means each entry can be traced to the person who made it and when, can be read, was written at the time, is the first record or a true copy, and is correct. Values copied from the record into a spreadsheet or report are data too, and the same expectations follow them.

Source: WHO Technical Report Series No. 1033, Annex 4: WHO Guideline on data integrity · Guide: read more

Annual product review / product quality review (APR, PQR)

A regular, usually annual, review of each product to confirm the process is consistent and the specifications still fit, and to find trends and improvements. EU GMP Chapter 1 (1.10) calls it the product quality review and lists what it should include at least, including critical in-process controls and finished product results, failed batches, significant deviations and the effectiveness of corrective and preventive actions. In the US, 21 CFR 211.180(e) requires records to be kept so their data can be evaluated at least annually, which is the annual product review. Much of the input comes from batch records, so the review is only as sound as the values taken from them.

Source: EudraLex Volume 4, EU GMP Chapter 1: Pharmaceutical Quality System, paragraph 1.10 · Guide: read more

Audit trail

A secure record of who created, changed or deleted data, what changed, when and why, kept without obscuring or overwriting the original (MHRA GXP data integrity guidance, 6.13). In a computerised system it is generated automatically; on a paper batch record the single-line correction with initials, date and reason plays the same part. EU GMP Annex 11 (clause 9) asks for audit trails based on risk, with the reason for changes to GMP-relevant data documented, and 21 CFR Part 11 requires them for electronic records. A system that holds GMP values taken from batch records will usually need one, based on risk, so that any change to a value can be traced.

Source: MHRA GXP Data Integrity Guidance and Definitions (March 2018), section 6.13

Batch certification

The Qualified Person’s certification, in a register or equivalent document, that a batch meets the requirements of Article 51 of Directive 2001/83/EC; it is the quality release of the batch before it is released for sale or distribution (EU GMP Annex 16 glossary). Before certifying, the QP must be sure, among other points, that all records are complete and endorsed by appropriate personnel and that all required in-process controls and checks have been made (Annex 16, 1.7.11). The checks behind it, batch record review included, may be delegated to trained staff, but the QP stays responsible (Annex 16, 1.7).

Source: EudraLex Volume 4, EU GMP Annex 16: Certification by a Qualified Person and Batch Release

Batch manufacturing record (BMR)

The common European and international name for the record of how one batch was made. EU GMP Chapter 4 calls it the batch processing record (paragraph 4.20) and lists what it must hold, including dates and times of the main stages, the initials of the operators who performed each significant step, the quantities weighed and the yields obtained. In everyday use BMR can mean either the blank form or the executed copy, so it is worth saying which one is meant.

Source: EudraLex Volume 4, EU GMP Chapter 4: Documentation

Batch production record (BPR)

The US and ICH Q7 name for the batch record. ICH Q7 (section 6.5) says one should be prepared for each intermediate and API batch, checked before issue to be the correct version and a legible, accurate reproduction of the master production instruction, and numbered with a unique batch number. In 21 CFR 211.188 the same document is the batch production and control record. BPR and BMR describe the same kind of record; which term a site uses usually follows its regulator and its history.

Source: ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, section 6.5

Computer software assurance (CSA)

A risk-based approach to establishing confidence that software used in production or the quality system works as intended, putting the most assurance effort and testing where a failure would matter most. FDA set it out in guidance from its device and biologics centres (CDRH and CBER), first final in September 2025 and reissued in February 2026 to align with the Quality Management System Regulation. It is written for medical device manufacturers; its principles are also discussed for pharmaceutical computerised system validation, for example in GAMP 5 second edition.

Source: FDA Guidance: Computer Software Assurance for Production and Quality Management System Software

Continued process verification (CPV)

The third stage of process validation in FDA’s 2011 guidance: assuring during routine production that the process remains in a state of control. In practice it means collecting process parameters, in-process results and quality attributes batch after batch, charting them and acting on trends. EU GMP Annex 15 calls the equivalent activity ongoing process verification. Where batch records are on paper, the data for CPV must first be taken off the pages, so the accuracy of that transcription limits what the charts can show.

Source: FDA Guidance for Industry: Process Validation: General Principles and Practices (2011) · Guide: read more

Correction (on a GMP record)

A change to an entry already written on a record. EU GMP Chapter 4 (paragraph 4.9) says any alteration should be signed and dated, should leave the original information readable, and where appropriate should record the reason. In practice that means a single line through the wrong value, the new value beside it, and the initials, date and reason; correction fluid, overwriting and erasing are not accepted. When values are taken off a page, a corrected entry needs care: the value that counts is the new one, and the struck-through one must not be read in its place.

Source: EudraLex Volume 4, EU GMP Chapter 4: Documentation, paragraph 4.9 · Guide: read more

Corrective and preventive action (CAPA)

The system for acting on problems: a corrective action removes the cause of a nonconformity that has happened so that it does not recur, and a preventive action removes the cause of one that could happen (ICH Q10 glossary, after ISO 9000). ICH Q10 (3.2.2) expects CAPAs to follow investigations of complaints, rejections, deviations, audits, inspections and trends from process and quality monitoring, with a structured search for the root cause scaled to the risk. Batch record errors that keep coming back, such as the same entry missed on the same form, are a common reason to open one.

Source: ICH Q10 Pharmaceutical Quality System, section 3.2.2 and glossary

Critical process parameter (CPP)

A process parameter whose variability has an impact on a critical quality attribute and therefore should be monitored or controlled to ensure the process produces the desired quality (ICH Q8(R2) glossary). Which parameters are critical depends on the product and process; a drying temperature or a mixing time can be one. CPPs are named in the control strategy, printed on the batch record with their limits, and are among the first values trended in continued process verification and product quality reviews.

Source: ICH Q8(R2) Pharmaceutical Development, glossary · Guide: read more

Critical quality attribute (CQA)

A physical, chemical, biological or microbiological property or characteristic that should be within an appropriate limit, range or distribution to ensure the desired product quality (ICH Q8(R2) glossary). Assay, content uniformity, dissolution and impurities are typical CQAs of a tablet. CQAs are mostly measured by the laboratory and reported on certificates of analysis, while the batch record holds the process parameters and in-process results linked to them.

Source: ICH Q8(R2) Pharmaceutical Development, glossary · Guide: read more

Deviation

A departure from an approved instruction or established standard (ICH Q7 glossary). On a batch record that might be a parameter outside its printed limits, a step done out of order or a missing signature; it is documented and explained, investigated if critical (ICH Q7, 2.16), and reviewed as part of batch record review before the batch is released (6.72). Which excursions count as deviations, for example a value outside the normal operating range but inside the proven acceptable range, is set by each site’s procedures.

Source: ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, glossary · Guide: read more

Draft EU GMP Annex 22 (Artificial Intelligence)

A proposed new annex to the EU GMP guide on artificial intelligence, put out for consultation with revised Chapter 4 and Annex 11 from 7 July to 7 October 2025. As of November 2026 it is still a draft and not part of EudraLex Volume 4. The draft covers machine learning models used in critical GMP applications, limits them to static models with deterministic output, and says generative AI and large language models should not be used in critical GMP applications. After the consultation, the drafting group discussed allowing them, and dynamic and probabilistic models, under a fully documented, risk-based control strategy (EMA workshop report, 2 October 2026), so the final scope may differ. It also sets expectations for intended use, test data, acceptance criteria and the role of the human in the loop.

Source: European Commission: Stakeholders' consultation on EudraLex Volume 4, Chapter 4, Annex 11 and new Annex 22

Electronic batch record (eBR)

A batch record created and completed in a computerised system, usually a manufacturing execution system, instead of on paper. Entries are captured as data with the user, date and time, and limits can be checked as values are entered. EU GMP Chapter 4 says its documentation rules apply to all media and that many records exist in hybrid forms, part electronic and part paper (paragraph 4.1); the system itself falls under Annex 11 in the EU and 21 CFR Part 11 in the US. Many sites still run paper or hybrid records beside, or instead of, an eBR.

Source: EudraLex Volume 4, EU GMP Chapter 4: Documentation

EU GMP Annex 11

The annex to the EU GMP guide on computerised systems, in its January 2011 revision. It applies to all computerised systems used as part of GMP-regulated activities and covers risk management, suppliers, validation, data, accuracy checks on critical data entered by hand, audit trails, security and electronic signatures. A revised Annex 11 went out for consultation in July 2025 together with Chapter 4 and a new Annex 22; as of November 2026, EudraLex Volume 4 still lists the 2011 text.

Source: EudraLex Volume 4, EU GMP Annex 11: Computerised Systems (2011)

EU GMP Annex 16

The annex to the EU GMP guide on certification by a Qualified Person and batch release, revised in 2015 and in operation since 15 April 2016. It sets out what the QP must be sure of before certifying a batch, from the supply chain and audits to complete, endorsed records and in-process controls, and how to handle an unexpected deviation. For batch records, it is the reason they must be complete and reviewed before a batch is certified.

Source: EudraLex Volume 4, EU GMP Annex 16: Certification by a Qualified Person and Batch Release

Executed batch record

The batch record once the batch has been made: the issued copy of the master record with every weight, reading, time, signature and check filled in on the shop floor. 21 CFR 211.188 requires batch production and control records for each batch, starting from an accurate reproduction of the master record that has been checked, dated and signed. On paper it is usually a bundle of handwritten pages, later scanned or archived, and it is the primary source for the batch’s process data, its review and its release.

Source: 21 CFR 211.188 Batch production and control records

GAMP 5

ISPE’s guide to a risk-based approach to compliant GxP computerised systems; the second edition was published in 2022. It is industry guidance, not regulation, but it is widely used to plan the validation of computerised systems, scaling the effort to the risk and drawing on supplier documentation where that makes sense. The second edition stresses critical thinking by subject matter experts, accepts iterative software development, discusses computer software assurance, and adds appendices on topics including AI, machine learning and cloud services.

Source: ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition)

Good documentation practice (GDP)

The rules for how GMP records are written, corrected and kept so that they meet data integrity principles. PIC/S PI 041-1 defines good documentation practices as the measures that ensure documentation, paper or electronic, meets data management and integrity principles such as ALCOA+. On a batch record that means indelible ink, legible entries made at the time by the person who did the work, single-line corrections with initials, date and reason, and no blank fields left open. GDP also stands for good distribution practice, so many documents write GDocP to avoid confusion.

Source: PIC/S PI 041-1 Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments, glossary · Guide: read more

In-process control (IPC)

A check made during production to monitor the process and, if needed, adjust it, or to make sure the material conforms to its specification (ICH Q7 glossary). Typical examples are tablet weight, hardness and thickness during compression, or pH during a reaction. IPC results are written on the batch record with their acceptance limits and are often the most numerous values on it, which makes them a main source of data for trending.

Source: ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, glossary · Guide: read more

Late entry

An entry written on a record after the action it describes, for example a weight filled in later from a balance printout. GMP expects records to be made at the time: the WHO data integrity guideline says data should be recorded when generated, “not before or at a later stage” (TRS 1033, Annex 4). Regulations do not define a late entry; company procedures usually allow one only as an exception, marked as late, with the date it was actually written, the reason and the source used, and never back-dated. When values are taken from the record, that note matters: the time beside a late entry may not be when the step happened.

Source: WHO Technical Report Series No. 1033, Annex 4: WHO Guideline on data integrity · Guide: read more

Line clearance

A documented check, before an operation starts, that the room, line and equipment hold nothing left from the previous one: no product, materials, labels or documents not needed for the current batch. EU GMP Chapter 5 asks for this before processing (5.40) and before packaging (5.50), where the line clearance should follow “an appropriate check-list”. On a batch record it usually appears as a checklist with the operator’s and verifier’s signatures, dates and times at the start of each stage.

Source: EudraLex Volume 4, EU GMP Chapter 5: Production

Master batch record (MBR)

The approved, blank template from which each batch’s record is issued: the formula, the steps, the parameters with their limits, and the places for entries and signatures. ICH Q7 (section 6.4) calls it the master production instructions and says they should be prepared, dated and signed by one person and independently checked, dated and signed by a person in the quality unit. US rules call it the master production and control record; EU GMP calls it the manufacturing formula and processing instructions. Because it carries the printed limits and labels, it is the reference for what each entry on an executed record should contain.

Source: ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, section 6.4

Master production and control record

The US regulatory name for the master batch record. 21 CFR 211.186 requires one for each drug product and each batch size, prepared, dated and signed by one person and independently checked, dated and signed by a second. It must state, among other things, the components and their quantities, the theoretical yield with the maximum and minimum percentages beyond which an investigation is required, and complete manufacturing and control instructions with specifications. Each executed batch record starts as a checked reproduction of it (21 CFR 211.188(a)).

Source: 21 CFR 211.186 Master production and control records

Normal operating range (NOR)

The range around a parameter’s target within which the process normally runs, given the variability that cannot always be controlled. NOR has no ICH definition: EMA’s 2017 question-and-answer paper says “NOR is not an established ICH term” and describes it this way, adding that a range which affects the quality of the output needs a proven acceptable range or a design space instead. On a batch record it is usually the narrower of the two ranges printed beside an input, and what happens when a value leaves it is set by the site’s procedures.

Source: EMA Questions and answers: Improving the understanding of NORs, PARs, DSp and normal variability of process parameters (EMA/CHMP/CVMP/QWP/354895/2017) · Guide: read more

Out of trend (OOT)

A result that does not follow the expected trend, compared with other batches or with earlier results, even though it may still be within specification. The MHRA’s out-of-specification guidance describes an OOT result as generally a stability result of this kind, and notes that starting materials and in-process samples can also give out-of-trend data. In process data taken from batch records, an OOT value can be the first sign of drift, and it is also what a transcription slip such as a misplaced decimal point looks like. How a trend is defined, and when it triggers an investigation, is set by site procedures.

Source: MHRA: Out of specification investigations (OOS and OOT guidance) · Guide: read more

Proven acceptable range (PAR)

A characterised range of a process parameter for which operation within the range, while keeping other parameters constant, will result in producing a material meeting relevant quality criteria (ICH Q8(R2) glossary). On a batch record it is the wider of the two ranges usually printed beside an input.

Source: ICH Q8(R2) Pharmaceutical Development, glossary · Guide: read more

Qualified Person (QP)

The person an EU manufacturing or import authorisation holder must always have at its disposal (Article 48 of Directive 2001/83/EC), responsible under Article 51 for making sure each batch has been manufactured and checked in line with the law and its marketing authorisation. The QP certifies each batch before release for sale, as described in EU GMP Annex 16. To do so the QP relies on the quality system, including batch records that are complete and endorsed by the right people.

Source: Directive 2001/83/EC on the Community code relating to medicinal products for human use, Articles 48 to 51 (consolidated text)

Reconciliation

A comparison of the quantities issued, used, returned and destroyed for a batch, to show that everything is accounted for. EU GMP Chapter 5 asks for checks on yields and reconciliation of quantities (5.8), and for any significant or unusual discrepancy between bulk product, printed packaging materials and units produced to be investigated before release (5.61). On a batch record it is usually a table of counts or weights with a calculated difference and an acceptance limit, often for labels, where 21 CFR 211.125 sets the same expectation in the US.

Source: EudraLex Volume 4, EU GMP Chapter 5: Production

Review by exception (RBE)

Reviewing a record by looking in detail only at what a system has flagged as abnormal, such as a value outside its limits, a changed entry or a missed step, instead of reading every entry. PIC/S PI 041-1 names review by exception as one focus of audit trail review, and defines an exception report as a validated search tool that identifies predetermined abnormal data or actions for the reviewer. In batch record review it is mostly used with electronic batch records, where entries are checked as they are made; a paper record has no such check until its entries have been captured and checked. How far a site may rely on it is a decision for its quality system.

Source: PIC/S PI 041-1 Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments

Second-person verification

A second, independent person checks an entry or an action and signs or initials to say so, usually in a “checked by” or “verified by” column on the batch record. PIC/S PI 041-1 (section 8.8) expects records of critical process steps to be reviewed or witnessed by independent, designated personnel at the time of the operation, then reviewed in production and by the quality unit before release. US rules ask for the same on weighing and on each component added (21 CFR 211.101), and EU GMP Annex 11 asks for an additional check on critical data entered by hand. A verifier’s initials show that a check was recorded, not what was compared, so procedures define what the second person must look at.

Source: PIC/S PI 041-1 Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments, section 8.8 · Guide: read more

Transcription (of GMP data)

Copying a value from one record into another, for example from a balance printout onto the batch record, or from the batch record into a spreadsheet for trending. Each copy is a chance to drop a decimal point, swap digits or misread a date. The MHRA GXP data integrity guidance says manual transcriptions should be verified by a second person or a validated system, and PIC/S PI 041-1 expects the original data to be kept after transcription. Taking process data off paper batch records for CPV or a product quality review is transcription in this sense, so the same checks are usually expected.

Source: MHRA GXP Data Integrity Guidance and Definitions (March 2018), section 6.11.2 · Guide: read more

True copy

A copy of an original record that has been verified, by a dated signature or by a validated process, to hold the same information as the original, including its context, content and structure (MHRA GXP data integrity guidance, 6.11.2; the WHO data integrity guideline uses the same words). A scan of a paper batch record may be kept in place of the paper only if a documented system verifies and records the integrity of the copy. A scan made for convenience is a copy, not a true copy, until that check has been done and recorded.

Source: MHRA GXP Data Integrity Guidance and Definitions (March 2018), section 6.11.2

Yield

The quantity of product obtained at a stage of manufacture. 21 CFR 210.3 defines theoretical yield as the quantity that would be produced with no loss or error, actual yield as the quantity actually produced, and percentage of theoretical yield as the ratio of the two. Master records state the expected yield with limits, and a result outside them is a discrepancy to investigate (21 CFR 211.186 and 211.192; EU GMP Chapter 5, 5.44). Stage yields are among the values most often trended across batches.

Source: 21 CFR 210.3 Definitions · Guide: read more